|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 267/14 | |
| C07D 413/04 | |||
| C07D 413/12 | |||
| C07D 413/14 | |||
| C07D 498/04 | |||
| A61K 31/553 |
| (11) | Number of the document | 2726469 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12735400.9 |
| Date of filing the European patent application | 2012-06-29 | |
| (97) | Date of publication of the European application | 2014-05-07 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/045021 |
| Date | 2012-06-29 |
| (87) | Number | WO 2013/006463 |
| Date | 2013-01-10 |
| (30) | Number | Date | Country code |
| 201161503980 P | 2011-07-01 | US |
| (72) |
CORKEY, Britton, Kenneth, US
ELZEIN, Elfatih, US
JIANG, Robert, H., US
KALLA, Rao, V., US
KOLTUN, Dmitry, US
LI, Xiaofen, US
MARTINEZ, Ruben, US
PARKHILL, Eric, Q., US
PERRY, Thao, US
ZABLOCKI, Jeff, US
VENKATARAMANI, Chandrasekar, US
GRAUPE, Michael, US
GUERRERO, Juan, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | OXAZEPINES AS ION CHANNEL MODULATORS |
| OXAZEPINES AS ION CHANNEL MODULATORS |